Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
464.5 USD | +2.02% | +3.26% | +13.41% |
05-31 | BMO Capital Adjusts Price Target on Vertex Pharmaceuticals to $500 From $480 | MT |
05-31 | Vertex Pharmaceuticals Insider Sold Shares Worth $1,478,068, According to a Recent SEC Filing | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.41% | 118B | |
+12.90% | 106B | |
-3.17% | 24.28B | |
+1.34% | 21.96B | |
-9.35% | 18.16B | |
-42.12% | 16.37B | |
-17.65% | 15.56B | |
+4.64% | 13.63B | |
+31.74% | 12.27B | |
+82.53% | 8.87B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Transcript : Vertex Pharmaceuticals Incorporated, Q4 2020 Earnings Call, Feb 01, 2021